4-fluoro-1-hydroxymethyl-admantane,1283721-00-5-Amadis Chemical

Home > Product Catalog > Building Blocks > 4-fluoro-1-hydroxymethyl-admantane

[CAS No.1283721-00-5] A1289487 4-fluoro-1-hydroxymethyl-admantane 95%

Search after editing

Catalog No.: A1289487

Cas No.: 1283721-00-5

Molecular Formula: C₁₁H₁₇FO

Molecular Weight: 184.25

MDL NO: MFCD18800685

EINECS:

Order & Inquiry & Tech Support

Tel: 0086-571-89925085
Order & Inquiry: sales@amadischem.com
Tech Support: tech@amadischem.com

Request Quote

*All chemicals from Amadis Chemical are for laboratory or manufacturing use only.

Quality Control of [1283721-00-5]

NMR

CNMR

HPLC

LC-MS

Related Doc. of[1283721-00-5]

SDS

Specification

MOL

SDF

Product Details [1283721-00-5]

Synonyms: 4-fluoro-1-hydroxyMethyl-adMantane

Appearance:

Storage: Store in 2-8°C for long term (months)

Boiling point: 263.1±13.0 °C(Predicted)

Melting point:

Flash point:

Pubchem ID: 112758208

Smiles: C1C2CC3CC(C2)(CC1C3F)CO

InchiKey: NUMVQWAOMKYOCQ-UHFFFAOYSA-N

Inchi: InChI=1S/C11H17FO/c12-10-8-1-7-2-9(10)5-11(3-7,4-8)6-13/h7-10,13H,1-6H2

Safety [1283721-00-5]

GHS Pictogram:

Signal Word: Warning

Class:

Precautionary Statements: P261;P305+P351+P338

UN No.:

Hazard Statements: H302;H315;H319;H335

Packing Group:

Literatures [1283721-00-5]

Sorry, the literature is not available.

Similar of [1283721-00-5]

A1071798 1781384-06-2

[trans-4-fluorocyclohexyl]methanol

Reason:Building Blocks

A1071951 1782531-62-7

[cis-4-fluorocyclohexyl]methanol

Reason:Building Blocks

A1075566 1903422-68-3

[trans-2-fluorocyclohexyl]methanol

Reason:Building Blocks

A1075574 1903427-96-2

[cis-2-fluorocyclohexyl]methanol

Reason:Building Blocks

A1095329 94994-16-8

{4-fluorobicyclo[2.2.2]octan-1-yl}methanol

Reason:Building Blocks

A1038018 1206675-26-4

(2-Fluorocyclohexyl)methanol

Reason:Building Blocks

Description [1283721-00-5]

Sorry, the product description is not available.

Browsing history

A1291171 881733-45-5

1-(5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate

Inquiry

Detail

A1292767 117811-12-8

5-Hydroxy Desloratadine

Inquiry

Detail

A920252 167951-80-6 97%

3,3,3-Trifluoropropylene Carbonate

$170.00 25g

Detail

A1291072 956011-26-0

1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid

Fluticasone furoate impurity 13

Inquiry

Detail

A1289486 1283734-84-8

1-benzyl-3-(1-benzyl-2-oxo-piperidin-4-ylidene)piperidine-2,4-dione

Inquiry

Detail

A1291172 881676-90-0

5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde

Inquiry

Detail

A1292800 1132709-15-9

Bortezomib Impurity 6

Inquiry

Detail

A1291063 97164-57-3

(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Inquiry

Detail

A1291272 753498-27-0

5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one)

Inquiry

Detail

A1292789 1138246-96-4

2-((1S,5R,6R)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid

Inquiry

Detail

A1291079 950781-91-6

2,3,4,5-tetrahydro-1H-1,5-methanobenzo[d]azepine-6,8-diamine hydrochloride

Inquiry

Detail

A1293864 2022974-96-3

(Cys(Acm)6.12)-Orexin A (human, mouse, rat)

Inquiry

Detail

A1294937 657-35-2

Benzene, (1,1-difluoroethyl)-

Inquiry

Detail

A1293880 201985-44-6

H-Ala-Leu-Tyr-Leu-βNA

Inquiry

Detail

A1291952 2180628-04-8

Landiolol Impurity 30

Inquiry

Detail

A1291935 2204280-33-9

N-(trans-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

Inquiry

Detail

A1292687 123663-50-3

Iguratimod Impurity 12

Inquiry

Detail

A1292785 114-49-8

Scopolamine Hydrobromide

Inquiry

Detail

A1292773 1173203-26-3

Bisoprolol EP Impurity T

Inquiry

Detail

A1289488 1283720-90-0

2H-Pyrazolo[4,3-c]pyridin-3-ol, 7,7-difluoro- 4,5,6,7-tetrahydro-

Inquiry

Detail

A1292809 112246-66-9

Carbocisteine Impurity 9

Inquiry

Detail

A1292783 1147548-83-1

Tizanidine EP Impurity C

Inquiry

Detail

A1295068 1890776-30-3

1-(1,1-difluoropropyl)-2-methyl-Benzene

(5RS)-5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]- phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)- ethyl]thiazolidine-2,4-dione

Inquiry

Detail

A1291064 96948-64-0

4-(2-(tert-butylamino)-1-hydroxyethyl)phenol

Inquiry

Detail

A1292763 1182559-53-0

N-(3,4-diethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide

Inquiry

Detail

A1291322 68128-53-0

4-O-[4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3- (hydroxymethyl)cyclohex-2-enyl]amino]-α-Dglucopyranosyl]-D- glucopyranose

Inquiry

Detail

A1292701 1229225-43-7

Tetrahydro Cinacalcet Hydrochloride

Inquiry

Detail

A1293802 245329-01-5

PAR-2 (6-1) amide (mouse, rat)

Inquiry

Detail

A1291074 952901-90-5

5-chloro-3-(N,N-dimethylsulfamoyl)thiophene-2-carboxylic acid

Inquiry

Detail

A1293795 250290-82-5

Boc-Gly-Phe-Gly-Lys-OH

Inquiry

Detail

A1292799 1132709-16-0

((S)-3-methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido) butyl)boronic acid

Thrombin (B 147-158) (human)

Inquiry

Detail

A1291166 89231-90-3

(S,Z)-3-(((1R,3aR,3'R,4R,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydrospiro[indene-4,2'-oxiran]-3'-yl)methylene)-4-methylenecyclohexan-1-ol

Inquiry

Detail

A1292878 102306-95-6

Etoposide EP Impurity H

Inquiry

Detail

A1292765 1179354-65-4

Iguratimod Impurity 33

Inquiry

Detail

A1295070 1890277-48-1

1-(chloromethyl)-4-(1,1-difluoropropyl)-Benzene

Inquiry

Detail

A1286621 2470436-09-8

2-(3-Bromo-isoxazol-5-yl)-ethylamine hydrochloride

Inquiry

Detail

A1292674 1242471-40-4

Edaravone Impurity 24

Inquiry

Detail

A1292787 114030-19-2

Lurasidone impurity 33

Inquiry

Detail

A1292664 1248478-42-3

Citalopram Impurity 49 Chloride

Inquiry

Detail

A1291573 2984992-63-2

mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one,

Inquiry

Detail

A1292769 117810-61-4

Desloratadine Impurity D

Inquiry

Detail

A1290410 2649505-20-2

2-Chlorophenanthro[3,4-b]benzofuran

Inquiry

Detail